InsiderClue
Stocks · Health care · In Vitro & In Vivo Diagnostic Substances

Cardio Diagnostics Holdings, Inc.

CDIO Clue Score43
United States Fiscal year ends December CIK 0001870144
$1.78 -4.81% Close, 12 Oct 2026
Alert on the numbers Alert on insider trades
Price $1.78 +584.62% Close, 12 Oct 2026

Closing prices at the end of each trading day, from 14 Jan 2022. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2021Revenue0.0Operating income−0.6Net income−0.6EPS, diluted−0.53Fiscal year 2022Revenue0.0 +5.4%Operating income−4.5Net income−4.7EPS, diluted−1.51Fiscal year 2023Revenue0.0 +1,696.3%Operating income−7.2Net income−8.4EPS, diluted−0.66Fiscal year 2024Revenue0.0 +104.5%Operating income−8.4Net income−8.4EPS, diluted−9.35Fiscal year 2025Revenue0.0 −57.5%Operating income−6.5Net income−6.5EPS, diluted−3.71
FY2021FY2022FY2023FY2024FY2025
Revenue 0.0 0.0 0.0 0.0 0.0
Growth +5.4% +1,696.3% +104.5% −57.5%
Operating income −0.6 −4.5 −7.2 −8.4 −6.5
Net income −0.6 −4.7 −8.4 −8.4 −6.5
Growth
EPS, diluted −0.53 −1.51 −0.66 −9.35 −3.71

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Operating marginNet margin
Fiscal year 2021Operating margin−68,862.2%Net margin−68,862.2%Fiscal year 2022Operating margin−478,784.3%Net margin−490,630.0%Fiscal year 2023Operating margin−42,440.4%Net margin−49,087.8%Free cash flow margin−36,612.0%Fiscal year 2024Operating margin−23,977.9%Net margin−24,028.2%Free cash flow margin−14,926.5%Fiscal year 2025Operating margin−43,737.5%Net margin−43,832.5%Free cash flow margin−39,893.1%
FY2021FY2022FY2023FY2024FY2025
Operating margin −68,862.2% −478,784.3% −42,440.4% −23,977.9% −43,737.5%
Net margin −68,862.2% −490,630.0% −49,087.8% −24,028.2% −43,832.5%
Free cash flow margin n/a n/a −36,612.0% −14,926.5% −39,893.1%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2021Operating cash flow−0.6Fiscal year 2022Operating cash flow−5.1Fiscal year 2023Operating cash flow−5.7Capital expenditure−0.6Free cash flow−6.2Fiscal year 2024Operating cash flow−5.0Capital expenditure−0.2Free cash flow−5.2Fiscal year 2025Operating cash flow−5.7Capital expenditure−0.2Free cash flow−5.9
FY2021FY2022FY2023FY2024FY2025
Operating cash flow −0.6 −5.1 −5.7 −5.0 −5.7
Capital expenditure n/a n/a −0.6 −0.2 −0.2
Free cash flow n/a n/a −6.2 −5.2 −5.9
Growth

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
Cash
Fiscal year 2021Cash0.0Shareholders’ equity1.1Fiscal year 2022Cash0.0Shareholders’ equity4.3Fiscal year 2023Cash0.0Shareholders’ equity3.0Fiscal year 2024Cash0.0Shareholders’ equity9.6Fiscal year 2025Cash0.0Shareholders’ equity7.0
FY2021FY2022FY2023FY2024FY2025
Cash 0.0 0.0 0.0 0.0 0.0
Shareholders’ equity 1.1 4.3 3.0 9.6 7.0

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Ratios

Percentages worked out from the filed figures; debt to equity in times. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2021 31 Dec 2021 FY2022 31 Dec 2022 FY2023 31 Dec 2023 FY2024 31 Dec 2024 FY2025 31 Dec 2025
Margins
−68,862.2% −478,784.3% −42,440.4% −23,977.9% −43,737.5%
−68,862.2% −490,630.0% −49,087.8% −24,028.2% −43,832.5%
−68,862.2% −490,630.0% −49,087.8% −24,028.2% −43,832.5%
n/a n/a −36,612.0% −14,926.5% −39,893.1%
Spending
3,492.6% 4,257.7% 850.8% 653.4% 4,325.2%
52,226.7% 463,184.5% 40,648.4% 19,836.9% 33,899.3%
n/a n/a 3,373.4% 615.5% 1,263.5%
Returns
−58.1% −108.4% −283.2% −87.7% −93.2%
−56.3% −74.6% −187.7% −79.0% −83.7%
Balance and payout
3.1% 31.2% 33.7% 10.0% 10.2%